TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543,739 | +526.5% | 172,069 | +31.0% | 0.00% | – |
| Q2 2023 | $86,794 | +23.9% | 131,308 | +49.5% | 0.00% | – |
| Q1 2023 | $70,039 | +31.3% | 87,813 | +272.0% | 0.00% | – |
| Q4 2022 | $53,352 | +11.2% | 23,607 | -5.4% | 0.00% | – |
| Q3 2022 | $48,000 | -81.9% | 24,962 | -65.2% | 0.00% | – |
| Q2 2022 | $265,000 | -76.9% | 71,651 | -59.2% | 0.00% | – |
| Q1 2022 | $1,148,000 | -30.8% | 175,755 | +23.5% | 0.00% | – |
| Q4 2021 | $1,658,000 | -28.8% | 142,345 | +13.8% | 0.00% | – |
| Q3 2021 | $2,328,000 | +203.9% | 125,094 | +246.4% | 0.00% | – |
| Q2 2021 | $766,000 | +64.4% | 36,110 | +57.3% | 0.00% | – |
| Q1 2021 | $466,000 | -44.0% | 22,961 | -26.7% | 0.00% | – |
| Q4 2020 | $832,000 | – | 31,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |